Ledger.Open graph →
SEC Form D · Amendment · filed February 6, 2017

AZTherapies, INC

Offering
$20.0M
Sold
$16.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Keith S. Greenfield · Boston, MAExec · DirectorPeter S. Conti · BOSTON, MADirectorDavid S. Taft · BOSTON, MADirectorRonald S. Tompkins · BOSTON, MADirectorJohn S. Porter · Boston, MADirectorRobert S. Warren · Boston, MAExecDavid R. Elmaleh · Boston, MAExec · DirectorSergei Nodelman · New York, NYExec · DirectorIvana B. Faltysova · Grand Cayman, Cayman IslandsExec · DirectorMiguel Bilbao · New York, NYDirectorSean D. Otoole · Atlanta, GADirectorStephen Quin · Vancouver, British Columbia, CanadaExecGavin Cooper · Vancouver, British Columbia, CanadaDirectorCary B. Marr · Grand Cayman, Cayman IslandsDirectorDon Guthrie · Seattle, WAExec · DirectorRobert Duncan · Vancouver, British Columbia, CanadaDirectorA. Daniel Greenshield · Seattle, WAExecWilliam Bennett · Vancouver, British Columbia, CanadaDirectorEric Stoppenhagen · Fremont, CADirectorGeoff Entress · Seattle, WAExec · DirectorJay Sujir · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗